What is LOPJLB’s current signal on ACRS?

LOPJLB’s latest quantitative signal on Aclaris Therapeutics, Inc. (ACRS) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is ACRS in?

Aclaris Therapeutics, Inc. (ACRS) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Aclaris Therapeutics, Inc. (ACRS) do?

Aclaris Therapeutics, Inc., a biopharmaceutical firm operating in the United States, is currently in the clinical development phase, focused on creating novel therapeutic agents for various immune-inflammatory conditions. The company's operations are divided into two primary divisions: the Therapeutics segment, dedicated to discovering and progressing innovative treatments to address crucial un…

Where is Aclaris Therapeutics, Inc. based / listed?

Aclaris Therapeutics, Inc. is based in US, listed on NASDAQ.

Aclaris Therapeutics, Inc. (ACRS)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$3.83+1.06%Close

SELLCRISIS · day 11

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONEBEST

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $535M
Beta: 0.80
P/E (TTM): -6.38

Short % float: 17.40%
Days to cover: 6.5
SI change: +13.2%

1W: -12.76%
1M: -30.49%

vs SPY 1W: -13.92%
vs SPY 1M: -33.48%

Industry peers

FMP comparable companies · ranked by market cap

ANABSELLAnaptysBio, Inc.$1.4BCRISISQ 25$45.95-0.56%
TRAXSELLFirst Tracks Biotherapeutics Inc$1.1BQ 81$31.85-0.50%
ODTXSELLOdyssey Therapeutics, Inc.$913MQ 38$19.00+4.86%
MLTXSELLMoonLake Immunotherapeutics$910MCRISISQ -0$10.82+2.27%
ALMSSELLAlumis Inc.$884MCRISISQ 2$7.16+2.73%
ATTOSELLAttovia Therapeutics, Inc.$698MQ -44$16.21-0.61%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Industry peers

Prediction markets

Company news